STOCK TITAN

Star Intermediate I (DNB) Stock News

DNB NYSE

Welcome to our dedicated page for Star Intermediate I news (Ticker: DNB), a resource for investors and traders seeking the latest updates and insights on Star Intermediate I stock.

Dun & Bradstreet Holdings Inc. appears in company news about business decisioning data and analytics, including Data Cloud products, sales and marketing intelligence, finance and risk solutions, and integrations that place global business data inside customer workflows. Recurring developments include product launches such as healthcare-focused datasets, partnerships for private-company deal sourcing and investigative software, and scheduled financial-results communications.

Corporate-status developments also include the company's completed 2025 merger, after which Dun & Bradstreet survived as a wholly owned subsidiary of an affiliate of investment funds managed by Clearlake Capital Group L.P.

Rhea-AI Summary

Dun & Bradstreet (NYSE:DNB) announced the Graph Connector for Microsoft 365 Copilot, offering developers and enterprises no-cost access to a curated sample of verified business data from the D&B Commercial Graph. The connector supports AI-powered workflows across sales, marketing, research, and supplier or partner discovery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

WEX (NYSE: C) and Impactive Capital reached a cooperation agreement to present a refreshed slate of 11 director nominees for the 2026 Annual Meeting, including three new independent directors: Kurt Adams, Ellen Alemany, and Lauren Taylor Wolfe. The Annual Meeting is rescheduled to May 14, 2026.

The company will separate the roles of Chair and CEO after the meeting; Melissa Smith will remain CEO and president. Impactive withdrew its separate nomination and agreed to support the revised slate; customary standstill, non-disparagement, and voting commitments apply.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Scale Asia Ventures (DNB) earned two finalist nominations at the Private Equity Wire® US Awards 2025: Performance of the Year: Venture Capital (Under $500 million) for SAV Fund I and Capital Raise of the Year: Co-invest for SAV Fund II. Winners are scheduled to be announced on November 6, 2025 in New York City.

The firm highlights an AI "barbell" strategy, late-stage portfolio companies including VAST (funding talks at ~$30 billion valuation) and Crusoe (raised ~US$1.4 billion), plus multiple exits from 2021–2025 that the firm says underpin its institutional LP traction and co-invest platform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Scale Asia Ventures (SAV) founding Managing Partner Wally Wang has been recognized on Business Insider's 2025 Seed 100 list, ranking #95 among top early-stage investors. The recognition highlights SAV's successful AI-focused investment strategy, particularly in enterprise software companies bridging Silicon Valley innovation with Asian markets.

Wang's notable investments include Weaviate, Argilla, Array, CAST AI, Fiddler AI, and AppZen. SAV's portfolio spans both AI infrastructure companies like Mastra and Tiny Fish, and vertical AI applications such as Solve Intelligence and HiggsField AI. The firm specializes in connecting portfolio companies with strategic customers across the U.S. and Asia, providing support in go-to-market strategies, hiring, and capital access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

Dun & Bradstreet (NYSE:DNB) has launched D&B Healthcare Insights, a comprehensive healthcare dataset designed to enhance sales and marketing intelligence for companies targeting the healthcare sector. The new solution, available as an add-on to D&B Hoovers, provides detailed information about healthcare organizations (HCOs) and healthcare providers (HCPs).

The platform combines D&B Hoovers' extensive database of over 320M companies and 485M contacts with healthcare-specific data covering more than 260,000 healthcare organizations. Users can access detailed information including facility profiles, operating room size, bed counts, procedure volumes, staffing numbers, and total visits. This healthcare dataset is the first in a series of new data offerings planned by Dun & Bradstreet for 2025.

[ "Launch of comprehensive healthcare-specific dataset expanding DNB's market reach", "Access to extensive database covering 260,000+ healthcare organizations", "Integration with existing D&B Hoovers platform enhancing product offering", "First in a series of new planned data offerings indicating growth strategy" ]
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Dun & Bradstreet (NYSE:DNB) has partnered with Chorus Intelligence to integrate its global business data into the Chorus Intelligence Suite (CIS). The collaboration will give CIS users direct access to Dun & Bradstreet's Data Cloud, which contains over 600 million business records.

The integration enables banking, financial services, law enforcement, and government organizations to perform real-time queries of entities and conduct bulk searches within Dun & Bradstreet's database. Users can identify hidden connections, verify beneficial ownership, and map complex corporate networks to combat financial crimes such as fraud, money laundering, and terrorist financing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Dun & Bradstreet (NYSE:DNB) has released its Global Business Optimism Insights report, revealing a concerning 6.5% decline in business optimism for Q3 2025, marking the third consecutive quarterly drop. The comprehensive survey of 10,000 business leaders across 32 economies highlights significant challenges in global trade and supply chains.

Key findings show the Global Supply Chain Continuity Index fell 9.7%, while the Business Investment Confidence Index dropped 13.1%. Manufacturing sectors were particularly impacted, with a 8.3% decline in sentiment versus 5.4% in services. The report indicates that 54% of business leaders expect trade tensions to persist or worsen, while only 46% anticipate de-escalation. Financial metrics show deterioration, with only 60% of businesses optimistic about borrowing costs, down from 70% last quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
none
-
Rhea-AI Summary

Dun & Bradstreet (NYSE: DNB) and Finquest have launched Cofinder, an AI-powered web-based platform designed to revolutionize deal sourcing for private equity professionals. The platform combines Dun & Bradstreet's extensive private company database with Finquest's AI search technology to uncover proprietary investment opportunities.

Key features include access to data on over 150 million businesses (including 50 million U.S.-based), 15 million verified executive-level contacts, and AI-enhanced search capabilities. Cofinder enables users to map niche markets, gain competitive advantages through off-market targets, streamline deal origination, and identify strategic buyers in the middle market. The platform is currently available in the U.S. and Canada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
none
-
Rhea-AI Summary
Dun & Bradstreet (NYSE: DNB) reported its Q1 2025 financial results, showing mixed performance. Revenue reached $579.8 million, up 2.7% YoY (3.6% on constant currency). The company posted a GAAP net loss of $15.8 million ($0.04 loss per share), improving from a $23.2 million loss in Q1 2024. Adjusted net income grew to $90.9 million ($0.21 per share). North America revenue increased 2.9% to $398.0 million, while International revenue rose 2.2% to $181.8 million. The company's adjusted EBITDA grew 4.8% to $210.9 million, with a margin of 36.4%. Following the definitive agreement with Clearlake Capital Group on March 23, 2025, DNB suspended forward-looking guidance and dividend payments, and halted its stock repurchase program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
Rhea-AI Summary

Dun & Bradstreet (NYSE:DNB), a global business data and analytics provider, is helping organizations navigate supply chain disruptions through comprehensive risk analysis and tariff impact assessments. The company's supply chain solutions have mapped 27 billion confirmed supplier relationships and provide visibility into approximately 30% of global trade flows.

A recent survey of 10,000 businesses revealed a 10.4% drop in supply chain continuity optimism from Q4 2024 to Q1 2025, attributed to challenges including freight costs, container shortages, route disruptions, and payment delays. To address these challenges, Dun & Bradstreet offers data-driven insights spanning multiple tiers of supply chain risk management, leveraging their database of over 600 million public and private companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none

FAQ

What is the current stock price of Star Intermediate I (DNB)?

The current stock price of Star Intermediate I (DNB) is $9.15 as of August 27, 2025.

What is the market cap of Star Intermediate I (DNB)?

The market cap of Star Intermediate I (DNB) is approximately 4.1B.